Atlas Lithium Corp
NASDAQ:ATLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atlas Lithium Corp
NASDAQ:ATLX
|
US |
|
S
|
Soho China Ltd
XBER:45S
|
CN |
|
Argenica Therapeutics Ltd
ASX:AGN
|
AU |
|
G
|
Guangxi LiuYao Group Co Ltd
SSE:603368
|
CN |
|
K
|
Kwangmu Co Ltd
KOSDAQ:029480
|
KR |
|
SHL Telemedicine Ltd
SIX:SHLTN
|
IL |
|
E
|
Erato Energy SA
WSE:ERA
|
PL |
Balance Sheet
Balance Sheet Decomposition
Atlas Lithium Corp
Atlas Lithium Corp
Balance Sheet
Atlas Lithium Corp
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
16
|
36
|
|
| Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
16
|
36
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
16
|
38
|
|
| PP&E Net |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
39
|
49
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
39
|
49
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
5
|
7
|
0
|
0
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-45%
|
1
+48%
|
1
-16%
|
1
+4%
|
1
+10%
|
1
-23%
|
1
+4%
|
1
-8%
|
2
+64%
|
6
+264%
|
44
+669%
|
58
+32%
|
88
+52%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
3
|
5
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
10
|
|
| Other Current Liabilities |
0
|
0
|
2
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
3
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
3
|
6
|
6
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
0
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
20
|
20
|
|
| Total Liabilities |
0
N/A
|
1
+829%
|
3
+409%
|
2
-50%
|
3
+52%
|
3
+27%
|
4
+13%
|
4
+4%
|
4
+17%
|
3
-40%
|
4
+50%
|
35
+772%
|
37
+5%
|
36
-2%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
8
|
0
|
0
|
0
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
36
|
39
|
42
|
44
|
46
|
47
|
49
|
51
|
52
|
55
|
60
|
102
|
144
|
172
|
|
| Additional Paid In Capital |
37
|
39
|
40
|
36
|
45
|
46
|
47
|
48
|
47
|
51
|
62
|
112
|
166
|
223
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Total Equity |
2
N/A
|
0
-84%
|
2
N/A
|
1
+73%
|
1
-158%
|
2
-43%
|
3
-38%
|
3
-5%
|
3
-25%
|
1
+69%
|
2
N/A
|
9
+423%
|
21
+139%
|
52
+144%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-45%
|
1
+48%
|
1
-16%
|
1
+4%
|
1
+10%
|
1
-23%
|
1
+4%
|
1
-8%
|
2
+64%
|
6
+264%
|
44
+669%
|
58
+32%
|
88
+52%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
4
|
5
|
13
|
16
|
27
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|